This is an Untapped Market
People In the United States Suffer From Osteoarthritis
14-55
Age Range: Aimed at Younger Patients Suffering from OA
The Growing Hip Preservation Market is worth Billions
Our Technology?
Expertise and Innovation
Sign up for Business News
Questions
About the
Technology?
Expertise and Innovation
Sign up for Business News
News
2024 OrthoPitch Winner!
We’re super proud of our CEO, Brad Estes, Ph.D., as he impressed the audience and judges alike to lead CytexOrtho to victory at the first inaugural AAOS OrthoPitch competition! Our sincere thanks to MCRA and American Academy of Orthopaedic Surgeons (AAOS) for giving...
AAOS OrthoPitch 2024
CytexOrtho is excited to be selected as a finalist at the inaugural OrthoPitch contest next week at AAOS! CytexOrtho’s CEO, Dr. Brad Estes, will be battling it out with three other startups for the prizes and bragging rights at a brand-new technology competition for...
Newsletter – January 2024
The January 2024 issue of the CytexOrtho newsletter covers our 2023 accomplishments, including receiving Breakthrough Device Designation from the FDA, and highlights what is on the horizon in 2024: the plan for hosting our first clinical trial and the launch of our...
News
2024 OrthoPitch Winner!
We’re super proud of our CEO, Brad Estes, Ph.D., as he impressed the audience and judges alike to lead CytexOrtho to victory at the first inaugural AAOS OrthoPitch competition! Our sincere thanks to MCRA and American Academy of Orthopaedic Surgeons (AAOS) for giving...
AAOS OrthoPitch 2024
CytexOrtho is excited to be selected as a finalist at the inaugural OrthoPitch contest next week at AAOS! CytexOrtho’s CEO, Dr. Brad Estes, will be battling it out with three other startups for the prizes and bragging rights at a brand-new technology competition for...
Newsletter – January 2024
The January 2024 issue of the CytexOrtho newsletter covers our 2023 accomplishments, including receiving Breakthrough Device Designation from the FDA, and highlights what is on the horizon in 2024: the plan for hosting our first clinical trial and the launch of our...